Literature DB >> 12523486

In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.

Anna Wesołowska1.   

Abstract

In recent years much attention has been focused on the functional importance of 5-HT5, 5-HT6 and 5-HT7 receptors in the pathogenesis of neuropsychiatric and other diseases. In this connection, intensive studies with ligands of these receptors are currently in progress. Recognition of the structural characteristics responsible for the binding of a ligand molecule to an appropriate receptor, and development of an active complex have reached an advanced stage in the search for selective compounds. This review was undertaken to summarize the results of structure-activity relationship studies with ligands of 5-HT5, 5-HT6 and 5-HT7 receptors. Additionally, some data on localization, pharmacological properties and the functional role of those receptors were reported.

Mesh:

Substances:

Year:  2002        PMID: 12523486

Source DB:  PubMed          Journal:  Pol J Pharmacol        ISSN: 1230-6002


  5 in total

1.  Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals.

Authors:  L Y Yeung; H F Kung; David T Yew
Journal:  Age (Dordr)       Date:  2010-05-28

Review 2.  Presynaptic control of serotonin on striatal dopamine function.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Psychopharmacology (Berl)       Date:  2010-10-16       Impact factor: 4.530

Review 3.  Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.

Authors:  C Stasi; M Bellini; G Bassotti; C Blandizzi; S Milani
Journal:  Tech Coloproctol       Date:  2014-01-15       Impact factor: 3.781

4.  Development and validation of quantitative structure-activity relationship models for compounds acting on serotoninergic receptors.

Authors:  Grażyna Zydek; Elżbieta Brzezińska
Journal:  ScientificWorldJournal       Date:  2012-04-24

5.  Bioisosteric matrices for ligands of serotonin receptors.

Authors:  Dawid Warszycki; Stefan Mordalski; Jakub Staroń; Andrzej J Bojarski
Journal:  ChemMedChem       Date:  2015-03-13       Impact factor: 3.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.